Lobectomy, Lung Cancer (Diagnosis), Sublobar Resection
Conditions
Brief summary
The trial was designed as a single-center, non-interventional, prospective observational study to explore the role of a multimodal digital device in analyzing subjective and objective recovery in lung cancer patients undergoing sublobar resection versus lobectomy.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
1. adult patients (age ≥ 18 years) 2. American Society of Anesthesiologists (ASA) grade of III or below 3. scheduled for VATS from March to December 2023
Exclusion criteria
1. age \<18 years 2. inability or poor compliance to use wearable devices 3. lack of smartphone 4. incomplete digital device data during hospitalization 5. patients with lymph node or distant metastasis
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Electronic patient-reported outcomes | From 1 day prior to surgery through hospital discharge (assessed up to 15 days). | The electronic patient-reported outcomes questionnaire includes pain, cough, shortness of breath, restless sleep, fatigue, drowsiness, walking difficulties, activity limitation, and distress(0 = no symptom, 10 = most severe). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Length of Hospital Stay | From the day of surgery until the day of discharge, assessed up to 15 days. | Total number of days spent in the hospital from admission to discharge. |
| Surgical Time | During the surgical procedure (from anesthesia induction until skin closure). | Duration of the surgery measured in hours. |
| Number of Lymph Nodes Dissected | During the surgical procedure (from anesthesia induction until skin closure). | The total count of lymph nodes harvested during the surgical procedure. |
Countries
China